Phase 3 INDIGO open-label extension findings demonstrated sustained clinical activity of obexelimab – – Additional analyses of secondary endpoints showed that significantly fewer patients experienced ...

A two-stage study of 340 participants in Singapore has identified twelve autoantibodies elevated in Parkinson's disease patients, linked to translation regulation and vascular biology.

Sjogren's disease study, while positive FB102 data in celiac disease offer a contrasting pipeline development.

ARGX's FB102 achieves its primary endpoint in a phase II celiac disease study, paving the way for late-stage development ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

New research shows the artificial sweetener sucralose slows autoimmune depigmentation in mice and suppresses human CD8+ T ...

Shares in Argenx were down 18% in European morning trading Thursday, wiping out the stock's gains in the year to date. If sustained until close, this would be the stock's biggest one-day percentage ...

Study met primary endpoint of change from baseline in the ratio of Vh:Cd (p=0.0176)First Phase 2 evidence that blocking CD122 can prevent ...

Autoimmune diseases are common, such as rheumatoid arthritis, psoriasis and type 1 diabetes, but despite their prevalence, ...

An international multidisciplinary group of 31 experts has updated consensus recommendations to guide the use of CAR T-cell ...

An Idaho State University biologist and her students are exploring new ways to fight autoimmune diseases afflicting millions.